Jersey proposes ban on disposable e-cigarette sales starting in 2025

Oct.31.2024

Jersey plans to ban the sale and supply of disposable e-cigarettes from April 2025, aligning with similar measures in the UK and Guernsey.

Jersey plans to ban the sale and supply of disposable e-cigarettes from April 2025, according to an October 30 BBC report. If passed, the government will update existing single-use plastic legislation to impose a complete ban on disposable e-cigarettes.

Andy Jehan told the States Assembly that a significant proportion of young people are using disposable e-cigarettes, raising social concerns. These devices cause serious environmental damage as most are not recycled.

"The widespread use of disposable e-cigarettes leads to problematic disposal methods. The materials used in each device, including plastic, metal and lithium batteries, are at odds with commitments to reduce waste, maximize resources and move towards a circular economy," said Jehan.

The proposal, which follows similar measures in the United Kingdom and Guernsey, is expected to be debated in the States Assembly as early as December 10.

References:

[1] Disposable vape ban to be debated in Jersey

Also Read:

[1] UK unveils e-cigarette tax plan, adding £2.20 per 10ml of e-liquid starting in 2026

[2] UK county backs disposable vape ban, stresses education over regulation

[3] UK outdoor smoking ban stalls amid government split, hospitality industry survival concerns

[4] Scotland delays ban on disposable vapes until June next year

[5] UK survey finds 80% of vapers in Northern Ireland skip age checks, retailers urged to improve ID checks

[6] UK's impending ban on disposable vapes draws mixed reactions from major supermarkets

[7] Experts warn new rechargeable e-cigarettes could evade upcoming ban

[8] Welsh government to ban disposable e-cigarettes from June 2025

[9] England to ban single-use e-cigarettes from June 2025

#Europe #Legislation #Disposable e-cigarettes

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

Product | Compatible with Terea Sticks and Supporting Dual Heating: HiTaste Unveils New Heated Tobacco Device

HiTaste has introduced its new HNB device, the F10, on social media, highlighting its wrap-around heating and dual-heating features. Similar “dual-heating” and “one-stick-two-sessions” designs were widely showcased at InterTabac 2025, signaling that this technical direction is emerging as a new competitive focus among HNB brands.

Nov.17 by 2FIRSTS.ai

Number of Vapers in Britain Surpasses Smokers for the First Time, Government Tightens Nicotine Regulations

For the first time, more people in Britain now vape than smoke. According to the Office for National Statistics (ONS), 10% of adults (5.4 million) regularly use e-cigarettes compared with 9.1% (4.9 million) who smoke cigarettes. The government credits vaping for the decline in smoking but plans tougher rules through the Tobacco and Vapes Bill, including a generational smoking ban and restrictions on nicotine pouch flavours, packaging, and sales.

Nov.05 by 2FIRSTS.ai

$200 Million Investment to Advance Smokeless Product Manufacturing at Reynolds

Reynolds American Inc. announced it will create 200 new manufacturing positions in 2026 at its Tobaccoville, North Carolina, Operations Center, bringing total new roles added over the past two years to more than 1,000. The company added 800 jobs between 2024 and 2025. These roles will support the continued growth of Velo Plus nicotine pouches and Reynolds’ expanding multi-category portfolio, aligned with its mission to build a smokeless world.